Latest Mucopolysaccharidosis Stories
- MPS IV A patients and families urge swift, publicly funded access to life-altering drug VIMIZIM(TM) - VANCOUVER, July 7, 2014 /CNW/ - The Canadian Society for Mucopolysaccharide
Approval delivers first pharmaceutical therapy for children and adults with ultra-rare, life-limiting disorder TORONTO, July 7, 2014 /CNW/ - BioMarin Pharmaceutical Inc.
LEXINGTON, Mass., June 3, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ: GEVA), a biopharmaceutical company
ORLANDO, Fla., June 2, 2014 /PRNewswire/ -- There is a rock anthem titled "School's Out for Summer".
ORLANDO, Fla., May 30, 2014 /PRNewswire/ -- Blair Chapin, a twelve-year-old little girl is dying.
New insight has been gained into treating an inherited disorder that creates serious neurological and behavioral disabilities in children and usually leads to death in the teen years.
BARCELONA, Spain, March 11, 2014 /PRNewswire/ -- - This gene therapy program is being developed in a public-private partnership between ESTEVE
BioMarin Pharmaceutical Inc. is a company focused on developing and commercializing biopharmaceuticals for serious diseases and other medical conditions.
- A serpent whose bite was fabled to produce intense thirst.